Literature DB >> 24022902

Coexistence of scleroderma with multiple myeloma: a rare association.

Smeeta Gajendra1, Richa Gupta, Ritu Gupta, Lalit Kumar.   

Abstract

Coexistence of scleroderma with multiple myeloma (MM) is an unusual finding with unclear significance. Only 13 cases of MM with scleroderma have been reported until now. We report a case of a 24-year-old man with 8-year history of progressive thickening of skin all over the body. Histopathology of skin lesion was consistent with scleroderma. Bone marrow biopsy showed interstitial and focal increase in plasma cells and increased bone marrow fibrosis. Skeletal survey showed osteopenia, but no osteolytic lesion or fracture. The patient was diagnosed as scleroderma with coexistence of immunoglobulin A, κMM. The patient recovered with improvement of skin lesions after 9 months of therapy with thalidomide and dexamethasone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24022902      PMCID: PMC3794227          DOI: 10.1136/bcr-2013-200639

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Hematologic disease in scleroderma syndromes.

Authors:  J A Doyle; S M Connolly; H C Hoagland
Journal:  Acta Derm Venereol       Date:  1985       Impact factor: 4.437

Review 2.  Cardiomyopathy and multiple myeloma. Complications of scleredema adultorum.

Authors:  D Rimon; M Lurie; S Storch; D Halon; S Eisenkraft; A Laor; L Cohen
Journal:  Arch Intern Med       Date:  1988-03

Review 3.  FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature.

Authors:  Milica Čolović; Vladimir Jurisic; Jelena Bila; Natasa Čolović; Vuk Palibrk
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

4.  [Scleredema adultorum and multiple myeloma (author's transl)].

Authors:  G W Korting; H J Gilfrich; K H Meyer zum Büschenfelde
Journal:  Arch Dermatol Forsch       Date:  1974-02-20

Review 5.  Scleredema adultorum associated with IgG-kappa multiple myeloma--a case report and review of the literature.

Authors:  E Hodak; R Tamir; M David; M Hart; M Sandbank; A Pick
Journal:  Clin Exp Dermatol       Date:  1988-07       Impact factor: 3.470

6.  Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis.

Authors:  G I Stables; P C Taylor; A S Highet
Journal:  Br J Dermatol       Date:  2000-04       Impact factor: 9.302

7.  Scleredema and smoldering myeloma.

Authors:  K T Schmidt; P Gattuso; H Messmore; M A Shrit; M Massa; S Welykyj
Journal:  J Am Acad Dermatol       Date:  1992-02       Impact factor: 11.527

8.  Marked and sustained improvement of systemic sclerosis following polychemotherapy for coexistent multiple myeloma.

Authors:  T Bachleitner-Hofmann; K Machold; R Knobler; J Drach; E Grumbeck; H Gisslinger
Journal:  Clin Exp Rheumatol       Date:  2002 Jan-Feb       Impact factor: 4.473

9.  Atypical scleroderma associated with multiple myeloma.

Authors:  H Nakanishi; K Takehara; Y Soma; Y Ishibashi
Journal:  Dermatologica       Date:  1989

10.  [Scleredema, acanthosis nigricans and IgA/Kappa multiple myeloma].

Authors:  L Valente; G C Velho; F Farinha; A Bernardo; P Ribeiro; A Massa
Journal:  Ann Dermatol Venereol       Date:  1997       Impact factor: 0.777

View more
  3 in total

1.  Crusted Scabies in Systemic Sclerosis with Plasma Cell Dyscrasia.

Authors:  Balkrishna P Nikam; Shraddha J Patil; Varsha Jamale; Mohan Kale
Journal:  Indian Dermatol Online J       Date:  2018 May-Jun

2.  Scleroderma Renal Crisis Associated With Microangiopathic Hemolytic Anemia in a Patient With Seronegative Scleroderma and Monoclonal Gammopathy.

Authors:  Mark Riley; Paul Der Mesropian; Ana Maheshwari; Mustafa Erdem Arslan; Parth Visrodia; Loay Salman; Ruben Peredo-Wende; Llewellyn Foulke; Krishnakumar Hongalgi
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

Review 3.  Systemic Sclerosis and Malignancy: A Review of Current Data.

Authors:  Nabil Zeineddine; Lara El Khoury; Joseph Mosak
Journal:  J Clin Med Res       Date:  2016-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.